Overview
Katsuya Watanabe practices practicing medicine in Yokohama, Japan.
Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Bullae, and Lung Adenocarcinoma.
They are actively involved in clinical research, co-authoring 19 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Katsuya Watanabe
Is Katsuya Watanabe a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Katsuya Watanabe is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Katsuya Watanabe participate in research or clinical trials?
Yes. Katsuya Watanabe has published 19 articles and abstracts on conditions like Lung Cancer. You can view a list of Katsuya Watanabe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- BullaeWatanabe isExperienced. Learn about Bullae.
- Lung AdenocarcinomaWatanabe isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerWatanabe isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Watanabe isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).